Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Cardiac valve repair devices are used in the Open-Heart surgery to repair the malfunctioning of valves. GlobalData uses proprietary data and analytics to provide a comprehensive report on the cardiac valve repair devices market in New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the cardiac valve repair devices market in New Zealand was Abbott Laboratories followed by Edwards Lifesciences, LivaNova and Medtronic.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Only mitral valve repair has been covered under this segment. Tricuspid and Aortic annuloplasty devices are not included here. Annuloplasty is a technique used to repair an enlarged annulus; either a ring or band is placed at the base of the heart valve. This annuloplasty device makes the opening of valve smaller and provides support to the valve so it can close more tightly. Mitral Valve Annuloplasty devices consist of the annuloplasty rings and bands that are used in the repair of mitral valves.
The cardiac valve repair devices market in New Zealand can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size cardiac valve repair devices in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
